This medicine helps people stop smoking. It works by blocking nicotine's effects in the brain, making it harder to feel the urge to smoke. It's available as a patch or a pill and is often used with counseling.
Every report comes from a Lived member, sent anonymously.
Have you tried Varenicline for Narcolepsy?
Varenicline is a prescription medicine that helps adults stop smoking. In tablet form it was first sold in the US under the brand name Chantix (Champix in Europe and elsewhere), and it is now widely prescribed as a generic. It is meant to be used alongside a quit plan and counseling or other support, not as a stand-alone fix. Among the medicines available for quitting, varenicline is one of the most effective. Large reviews of clinical trials found that it roughly doubles a person's chance of quitting compared with a placebo, and that it works better than bupropion (another prescription quit-smoking pill) or a single form of nicotine replacement such as a patch. The American Thoracic Society recommends it as a first choice for most adults, including people with depression or other mental health conditions. It is not recommended for people 16 or younger, because trials in teenagers did not show a benefit. The same ingredient is also sold as Tyrvaya, a nasal spray approved for dry eye disease. Tyrvaya has a different purpose, dose and side-effect profile, and the rest of this page is about the tablets unless it says otherwise.
Nicotine makes smoking rewarding by attaching to nicotinic receptors in the brain, which triggers the release of dopamine, a chemical messenger linked to pleasure and reward. Repeated smoking teaches the brain to expect that reward, and withdrawal and cravings follow when it stops. Varenicline attaches to the same receptors but stimulates them much more weakly than nicotine does. That mild stimulation takes the edge off cravings and withdrawal. At the same time, because varenicline is already occupying the receptors, nicotine from a cigarette cannot attach as easily, so smoking a cigarette while on the medicine tends to feel less satisfying. Both effects make it easier to stay quit, although motivation and support still matter. In the Tyrvaya nasal spray, varenicline acts on nerves inside the nose that signal the tear glands, increasing the eye's own tear production.
Varenicline tablets come in 0.5 mg and 1 mg strengths, and treatment begins with a one-week step-up to reduce nausea: one 0.5 mg tablet a day for three days, then 0.5 mg twice a day for four days, then 1 mg twice a day. Tablets are taken after eating with a full glass of water. There are three ways to time the quit. Many people set a quit date and start the tablets a week before it. Others start the medicine first and pick a quit day between the second and fifth week. People who do not feel able to stop all at once can cut down gradually over 12 weeks while taking it, aiming to stop completely by the end of that period. A standard course lasts 12 weeks. People who have quit by then are often advised to take another 12 weeks, which improves the chance of staying smoke-free. People with severe kidney disease take a lower dose, and anyone bothered by persistent side effects can ask about reducing the dose rather than stopping. Tyrvaya nasal spray is used as one spray in each nostril twice a day, about 12 hours apart.
Nausea is the most common side effect, affecting up to about 3 in 10 people on the full dose. It is usually mild and fades over time, and taking the tablet after food with plenty of water helps. Vivid or strange dreams, trouble sleeping, constipation, gas and vomiting are also common. Some symptoms that appear during a quit attempt, such as irritability, low mood or restlessness, can come from nicotine withdrawal itself rather than from the medicine. Mood and behavior changes have been reported, including depression, agitation, hostility, unusual thoughts and suicidal thoughts. A large safety trial found no increase in serious mental health side effects in people without a psychiatric history, and the increase in people with one was small and uncertain. Even so, anyone who notices unusual changes in mood, behavior or thinking, or thoughts of suicide, should stop the medicine and contact the prescriber right away. Family members can help by watching for these changes. Rarely, varenicline causes serious allergic reactions. Swelling of the face, lips, tongue or throat, especially with difficulty breathing, needs emergency care, and the medicine should be stopped. A skin rash with blistering or sores in the mouth also means stopping and contacting a clinician immediately. Sleepwalking has been reported; anyone who sleepwalks should stop the medicine and tell their prescriber. With Tyrvaya, sneezing right after a spray is very common, and cough and throat or nose irritation can occur.
Varenicline does not interact chemically with most medicines. The more important change comes from quitting itself: stopping smoking can alter how the body handles some drugs, such as theophylline (an asthma and lung medicine), warfarin (a blood thinner) and insulin, so these doses may need checking. Combining varenicline with a nicotine patch is sometimes recommended to improve quit rates, but it can increase nausea and other side effects, so it should be planned with the prescriber. Some people find that alcohol affects them more strongly on varenicline, occasionally with unusual or aggressive behavior and memory gaps. It is sensible to cut back on alcohol until you know how you respond. Drowsiness, dizziness and trouble concentrating have contributed to car accidents, so take care with driving or operating machinery at first. Seizures have been reported, mostly in the first month. People with a history of seizures should discuss this before starting, and anyone who has a seizure on treatment should stop the medicine and contact their clinician right away. People with existing heart or blood vessel disease may have a small increased risk of heart problems, a risk weighed against the large heart benefit of quitting smoking. New or worsening heart symptoms should be reported, and signs of a heart attack or stroke need emergency care. For pregnancy, available data have not shown an increase in major birth defects compared with continuing to smoke, but evidence is limited. Anyone pregnant or planning pregnancy should talk through the options with their clinician.
Many people notice that cigarettes become less satisfying and cravings ease in the early weeks of treatment. Nausea and odd dreams often show up early and then settle. Slipping and smoking a cigarette is common during a quit attempt; the usual advice is to keep taking the medicine and keep trying rather than stopping treatment. Varenicline improves the odds of quitting but does not guarantee it, and success is more likely with counseling, a quitline or other support. Follow-up with the prescriber helps adjust the dose for side effects and decide whether to continue for a second 12-week course. If a first attempt does not work, trying varenicline again later, once the reasons the attempt failed have been addressed, is a reasonable option. The weeks after finishing a course can be a vulnerable time for relapse, so a plan for handling cravings and triggers remains useful.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Varenicline, what you've noticed, or ask the community a question.